Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fruquintinib + Raltitrexed vs Fruquintinib in Advanced Colorectal Cancer
NCT04582981Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Sep 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltitrexed in colorectal cancer (CRC), sponsored by Fudan University. Status: unknown.
02
Drugs
raltitrexed
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04582981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04582981.